RIS ID
136192
Abstract
Small interfering RNA (siRNA) is a promising tool for gene therapy-based disease treatments. However, delivery of siRNA to the target cells requires a specific and reliable carrier system. Herein we describe a targeted carrier system that can deliver siRNA to cancer cells overexpressing the human epidermal growth factor 2 (HER2) receptor. Trastuzumab-conjugated poly(amido)amine dendrimers can be synthesized using the protocols described here.
Publication Details
Kulhari, H., Jangid, A. K. & Adams, D. J. (2019). Monoclonal antibody-conjugated dendritic nanostructures for siRNA delivery. Methods in Molecular Biology, 1974 195-201.